1. Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates
   David Teze et al, 2017, Scientific Reports CrossRef
2. Evaluation of the Effect of Chelating Arms and Carrier Agents on t he Radiotoxicity of TAT Agents
   Maryam Alvandi et al, 2023, Current Radiopharmaceuticals CrossRef
3. Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
   Hirohisa Nakamae et al, 2009, Cancer Research CrossRef
4. The Performance of two silica based ion exchange resins in the separation of 213Bi from its parent solution of 225Ac
   Mark A. Moore et al, 2018, Applied Radiation and Isotopes CrossRef
5. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
   Xianwen Hu et al, 2022, Frontiers in Oncology CrossRef
6. Albumin incorporation into recognising layer of HER2-specific magnetic nanoparticles as a tool for optimal targeting of the acidic tumor microenvironment
   Olga A. Kolesnikova et al, 2024, Heliyon CrossRef